A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...

While there’s no quick fix for these rising healthcare costs, there is a smarter plan that balances employee needs with ...

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...

The rise of GLP-1 weight loss drugs has been a game-changer for the grocery sector, and the dairy segment appears ...

Novo Nordisk A/S & Eli Lilly and Company cut prices for top diabetes drugs, boosting accessibility and potential revenue.

Greenhaven Road highlights Lifecore’s undervaluation and growth potential, urging investors to look past market misreads and ...

Eli Lilly has a leading position in a hot new drug category, but there's one notable problem to consider.

Somehow, it’s becoming even harder to get a GLP-1.

What are the major technical and analytical challenges associated with the separation of glucagon-like peptide-1 (GLP-1) ...

The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity ...

This holds true for other medications. For example, many young women are opting out of the birth control pill, influenced by social media discussions of side effects and messaging about how the ...